收藏本站
热门搜索: A3500  E1910  A1360  25200056  dmem  

FETAL HEMOGLOBIN KIT FITC 1 KIT

 
包装:
运保温度: 4°C
到货周期: 登录后查看
标准价: ¥客户可见
会员价: ¥客户可见
积分: 客户可见
 
登录之后可加入购物车购买,请您 
对比 收藏

运费与支付说明:

1.含干冰类产品有运费;

2. 必须现金付款或有信用额度的会员才可以直接发货,否则需要等待现金付款信息。

描述:

The Fetal Hemoglobin (HbF) Test is based on a monoclonal antibody directed to fetal hemoglobin (hemoglobin F). This antibody is conjugated with fluorescein (FITC). Commonly used, the fluorescein conjugates provide relatively high absorptivity, excellent fluorescence quantum yield, and good water solubility.

This reagent is intended for the identification followed by enumeration of fetal red blood cells. Fetal cells are identified by the presence of fetal hemoglobin using a flow cytometric method. The Fetal Hemoglobin Test may be used as an aid in identifying fetal-maternal hemorrhage and determining the need for immunoprophylaxis with immune globulin.
 

Antibody Specifications

Description:

Fetal Hemoglobin F (HbF), mouse IgG1 monoclonal

Label:

Fluorescein (FITC)

Validated Application:

Flow Cytometry

Species Reactivity:

Human

Ex/Em and laser configuration:

488/519 nm, blue laser

Clone ID:

HbF-1

Regulatory Status:

IVD


Antibody characteristics include:
• Clinical relevance
• in vitro diagonstic


Clinical Relevance
The Fetal Hemoglobin Test contains a monoclonal antibody directed to HbF that specifically recognizes fetal hemoglobin found in fetal erythrocytes. The test permits the enumeration of fetal erythrocytes in the maternal circulation as a result of a fetal-maternal hemorrhage, or leakage, of fetal cells into the maternal circulation. Hemorrhage of cells from an Rh+ fetus into the circulation of an Rh- mother may result in the formation of Rh-reactive antibodies in the mother. Rh hemolytic anemia in a subsequent Rh+ fetus may result from placental transfer of antibodies formed in the mother to the fetus. Although the volume of fetal erythrocytes found in the maternal circulation during pregnancy and immediately post-partum is reported to be small and of uncertain clinical significance in many cases, substantial hemorrhage may result from a number of causes including fetal or maternal trauma and placental defects.

Erythrocytes containing fetal hemoglobin may be found in individuals of any age, but with lower amounts of fetal hemoglobin compared to fetal red cells. These cells have been termed F cells. High levels of F cells may also exist in adults with a heterogeneous group of genetic disorders of uncertain etiology, referred to as Hereditary Persistence of Fetal Hemoglobin. Other clinical conditions causing significant levels of anemia may also result in elevated levels of F cells. Several clinical conditions have been described with increased levels of F cells. These conditions include hereditary anemic diseases such as sickle cell anemia and thalassemia major.


注意事项:

For Research Use Only. Not for use in diagnostic procedures.


相关图片

说明书

参考文献

本产品可用于的实验

最近浏览产品

京ICP备15036693号-2    京公网安备11010802025653    版权所有:北京逸优科技有限公司       0.73

 纠 错